[1]
|
Herberman, R.B., Nunn, M.E., Holden, H.T. and Lavrin, D.H. (1975) Natural Cytotoxic Reactivity of Mouse Lymphoid Cells against Syngeneicand Allogeneic Tumors. II. Characterization of Effector Cells. International Journal of Cancer, 16, 230-239. https://doi.org/10.1002/ijc.2910160205
|
[2]
|
Herberman, R.B., Nunn, M.E. and Lavrin, D.H. (1975) Natural Cytotoxic Reactivity of Mouse Lymphoid Cells against Syngeneic Acid Allogeneictumors. I. Distribution of Re-activity and Specificity. International Journal of Cancer, 16, 216-229. https://doi.org/10.1002/ijc.2910160204
|
[3]
|
Kiessling, R., Klein, E., Pross, H. and Wigzell, H. (1975) “Natural” Killer Cells in the Mouse. II. Cytotoxic Cells with Specificity for Mouse Moloney Leukemia Cells. Characteristics of the Killer Cell. European Journal of Immunology, 5, 117-121. https://doi.org/10.1002/eji.1830050209
|
[4]
|
Kiessling, R., Klein, E. and Wigzell, H. (1975) “Natural” Killer Cells in the Mouse. I. Cytotoxic Cells with Specificity for Mouse Moloney Leukemia Cells. Specificity and Distribution according to Genotype. European Journal of Immunology, 5, 112-117. https://doi.org/10.1002/eji.1830050208
|
[5]
|
Cantoni, C., Wurzer, H., Thomas, C. and Vitale, M. (2020) Escape of Tumor Cells from the NK Cell Cytotoxic Activity. Journal of Leukocyte Biology, 108, 1339-1360. https://doi.org/10.1002/JLB.2MR0820-652R
|
[6]
|
Voskoboinik, I., Whisstock, J.C. and Trapani, J.A. (2015) Per-forin and Granzymes: Function, Dysfunction and Human Pathology. Nature Reviews Immunology, 15, 388-400. https://doi.org/10.1038/nri3839
|
[7]
|
Takeda, K., Hayakawa, Y., Smyth, M.J., Kayagaki, N., Yamaguchi, N., Kakuta, S., et al. (2001) Involvement of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Insurveillance of Tumor Metastasis by Liver Natural Killer Cells. Nature Medicine, 7, 94-100. https://doi.org/10.1038/83416
|
[8]
|
Balsamo, M., Vermi, W., Parodi, M., Pietra, G., Manzini, C., Queirolo, P., Lonardi, S., Augugliaro, R., Moretta, A., Facchetti, F., et al. (2012) Melanoma Cells Become Resistant to NK-Cell-Mediated Killing When Exposed to NK-Cell Numbers Compatible with NK-Cell Infiltration in the Tumor. Eu-ropean Journal of Immunology, 42, 1833-1842.
https://doi.org/10.1002/eji.201142179
|
[9]
|
Huntington, N.D., Cursons, J. and Rautela, J. (2020) The Can-cer-Natural Killer Cell Immunity Cycle. Nature Reviews Cancer, 20, 437-454. https://doi.org/10.1038/s41568-020-0272-z
|
[10]
|
Guerra, N., Tan, Y.X., Joncker, N.T., Choy, A., Gallardo, F., Xiong, N., Knoblaugh, S., Cado, D., Greenberg, N.M. and Raulet, D.H. (2008) NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous Malignancy. Immunity, 28, 571-580. https://doi.org/10.1016/j.immuni.2008.02.016
|
[11]
|
Kaiser, B.K., Yim, D., Chow, I.T., Gonzalez, S., Dai, Z., Mann, H.H., Strong, R.K., Groh, V. and Spies, T. (2007) Disulphide-Isomerase-Enabled Shedding of Tumour-Associated NKG2D Ligands. Nature, 447, 482-486.
https://doi.org/10.1038/nature05768
|
[12]
|
Zingoni, A., Molfetta, R., Fionda, C., Soriani, A., Paolini, R., Cippitelli, M., Cerboni, C. and Santoni, A. (2018) NKG2D and Its Ligands: “One for All, All for One”. Frontiers in Immunology, 9, Article 476.
https://doi.org/10.3389/fimmu.2018.00476
|
[13]
|
Groh, V., Wu, J., Yee, C. and Spies, T. (2002) Tumour-Derived Soluble MIC Ligands Impair Expression of NKG2D and T-Cell Activation. Nature, 419, 734-738. https://doi.org/10.1038/nature01112
|
[14]
|
Fiegler, N., Textor, S., Arnold, A., Rolle, A., Oehme, I., Breuhahn, K., Moldenhauer, G., Witzens-Harig, M. and Cerwenka, A. (2013) Downregulation of the Activating NKp30 Ligand B7-H6 by HDAC Inhibitors Impairs Tumor Cell Recognition by NK Cells. Blood, 122, 684-693. https://doi.org/10.1182/blood-2013-02-482513
|
[15]
|
Schlecker, E., Fiegler, N., Arnold, A., Altevogt, P., Rose-John, S., Moldenhauer, G., Sucker, A., Paschen, A., Von Strandmann, E.P., Textor, S., et al. (2014) Metalloprotease-Mediated Tumor Cell Shedding of B7-H6, the Ligand of the Natural Killer Cell-Activating Receptor NKp30. Cancer Research, 74, 3429-3440.
https://doi.org/10.1158/0008-5472.CAN-13-3017
|
[16]
|
Glasner, A., Ghadially, H., Gur, C., Stanietsky, N., Tsu-kerman, P., Enk, J. and Mandelboim, O. (2012) Recognition and Prevention of Tumor Metastasis by the NK Receptor NKp46/NCR1. The Journal of Immunology, 188, 2509-2515.
https://doi.org/10.4049/jimmunol.1102461
|
[17]
|
Cagnano, E., Hershkovitz, O., Zilka, A., Bar-Ilan, A., Golder, A., Sion-Vardy, N., Bogdanov-Berezovsky, A., Mandelboim, O., Benharroch, D. and Porgador, A. (2008) Expression of Ligands to NKp46 in Benign and Malignant Melanocytes. Journal of Investigative Dermatology, 128, 972-979. https://doi.org/10.1038/sj.jid.5701111
|
[18]
|
Niehrs, A., Garcia-Beltran, W.F., Norman, P.J., Watson, G.M., Holze-mer, A., Chapel, A., Richert, L., Pommerening-Roser, A., Korner, C., Ozawa, M., et al. (2019) A Subset of HLA-DP Molecules Serve as Ligands for the Natural Cytotoxicity Receptor NKp44. Nature Immunology, 20, 1129-1137. https://doi.org/10.1038/s41590-019-0448-4
|
[19]
|
Bottino, C., Castriconi, R., Pende, D., Rivera, P., Nanni, M., Car-nemolla, B., Cantoni, C., Grassi, J., Marcenaro, S., Reymond, N., et al. (2003) Identification of PVR (CD155) and Nec-tin-2 (CD112) as Cell Surface Ligands for the Human DNAM-1 (CD226) Activating Molecule. Journal of Experimental Medicine, 198, 557-567.
https://doi.org/10.1084/jem.20030788
|
[20]
|
Zhang, Q., Bi, J., Zheng, X., Chen, Y., Wang, H., Wu, W., Wang, Z., Wu, Q., Peng, H., Wei, H., et al. (2018) Blockade of the Checkpoint Receptor TIGIT Prevents NK Cell Exhaustion and Elicits Potent Anti-Tumor Immunity. Nature Immunology, 19, 723-732. https://doi.org/10.1038/s41590-018-0132-0
|
[21]
|
Mamessier, E., Sylvain, A., Thibult, M.L., Houvenaeghel, G., Jacquemier, J., Castellano, R., Goncalves, A., Andre, P., Romagne, F., Thibault, G., et al. (2011) Human Breast Cancer Cells Enhance Self Tolerance by Promoting Evasion from NK Cell Antitumor Immunity. Journal of Clinical Investigation, 121, 3609-3622.
https://doi.org/10.1172/JCI45816
|
[22]
|
Castriconi, R., Dondero, A., Bellora, F., Moretta, L., Castellano, A., Loca-telli, F., Corrias, M.V., Moretta, A. and Bottino, C. (2013) Neuroblastoma-Derived TGF-β1 Modulates the Chemokine Receptor Repertoire of Human Resting NK Cells. The Journal of Immunology, 190, 5321-5328. https://doi.org/10.4049/jimmunol.1202693
|
[23]
|
Morvan, M.G. and Lanier, L.L. (2013) NK Cells and Cancer: You Can Teach Innatecells New Tricks. Nature Reviews Cancer, 16, 7-19. https://doi.org/10.1038/nrc.2015.5
|
[24]
|
Prager, I. and Watzl, C. (2019) Mechanisms of Natural Killer Cell-Mediated Cellular Cytotoxicity. Journal of Leukocyte Biology, 105, 1319-1329. https://doi.org/10.1002/JLB.MR0718-269R
|
[25]
|
Dewan, M.Z., Terunuma, H., Takada, M., Tanaka, Y., Abe, H., Sata, T., et al. (2007) Role of Natural Killer Cells in Hormone-Independent Rapid Tumor Formation and Spontaneous Metastasis of Breast Cancer Cells in Vivo. Breast Cancer Research and Treatment, 104, 267-275. https://doi.org/10.1007/s10549-006-9416-4
|
[26]
|
Gras Navarro, A., Bjorklund, A.T. and Chekenya, M. (2015) Therapeutic Potentialand Challenges of Natural Killer Cells in Treatment of Solid Tumors. Frontiers in Immunology, 6, Article 202.
https://doi.org/10.3389/fimmu.2015.00202
|
[27]
|
Palumbo, J.S., Talmage, K.E., Massari, J.V., La Jeunesse, C.M., Flick, M.J., Kombrinck, K.W., Hu, Z., Barney, K.A. and Degen, J.L. (2007) Tumor Cell-Associated Tissue Factor and Circulating Hemostatic Factors Cooperate to Increase Metastatic Potential through Naturalkiller Cell-Dependent and-Independent Mechanisms. Blood, 110, 133-141.
https://doi.org/10.1182/blood-2007-01-065995
|
[28]
|
Cekic, C., Day, Y.J., Sag, D. and Linden, J. (2014) Myeloid Expression of Adenosine A2A Receptor Suppresses T and NK Cell Responses in the Solid Tumor Microenvironment. Cancer Research, 74, 7250-7259.
https://doi.org/10.1158/0008-5472.CAN-13-3583
|
[29]
|
Dutta, A., Banerjee, A., Saikia, N., et al. (2015) Negative Regulation of Naturalkiller Cell in Tumor Tissue and Peripheral Blood of Oral Squamous Cellcarcinoma. Cytokine, 76, 123-130. https://doi.org/10.1016/j.cyto.2015.09.006
|
[30]
|
Conroy, M.J., Fitzgerald, V., Doyle, S.L., et al. (2016) The Microenvironment of Visceral Adipose Tissue and Liver Alter Natural Killer Cell Viability and Function. Journal of Leukocyte Biology, 100, 1435-1442.
https://doi.org/10.1189/jlb.5AB1115-493RR
|
[31]
|
Kloss, S., Chambron, N., Gardlowski, T., et al. (2015) Cetuxi-mab Reconstitutes Pro-Inflammatory Cytokine Secretions and Tumor-Infiltrating Capabilities of sMICA-Inhibited NK Cells in HNSCC Tumor Spheroid. Frontiers in Immunology, 6, Article 543. https://doi.org/10.3389/fimmu.2015.00543
|
[32]
|
Wennerberg, E., Sarhan, D., Carlsten, M., et al. (2013) Doxorubi-cin Sensitizes Human Tumor Cells to NK Cell- and T-Cell-Mediated Killing by Augmented TRAIL Receptor Signaling. International Journal of Cancer, 133, 1643-1652.
https://doi.org/10.1002/ijc.28163
|
[33]
|
Suck, G., Oei, V.Y., Linn, Y.C., Ho, S.H., Chu, S., Choong, A., Niam, M. and Koh, M.B. (2011) Interleukin-15 Supports Generation of Highly Potent Clinical-Grade Natural Killer Cells in Long-Term Cultures for Targeting Hematological Malignancies. Experimental Hematology, 39, 904-914. https://doi.org/10.1016/j.exphem.2011.06.003
|
[34]
|
Brehm, C., Huenecke, S., Quaiser, A., Esser, R., Bremm, M., Kloess, S., Soerensen, J., Kreyenberg, H., Seidl, C., Becker, P.S., et al. (2011) IL-2 Stimulated but Not Unstimulated NK Cells Induce Selective Disappearance of Peripheral Blood Cells: Concomitant Results to a Phase I/II Study. PLOS ONE, 6, e27351.
https://doi.org/10.1371/journal.pone.0027351
|
[35]
|
Hu, W., Wang, G., Huang, D., Sui, M. and Xu, Y. (2019) Can-cer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities. Frontiers in Immunology, 10, Article 1205.
https://doi.org/10.3389/fimmu.2019.01205
|
[36]
|
Sakamoto, N., Ishikawa, T., Kokura, S., Okayama, T., Oka, K., Ideno, M., Sakai, F., Kato, A., Tanabe, M., Enoki, T., et al. (2015) Phase I Clinical Trial of Autologous NK Cell Therapy Using Novel Expansion Method in Patients with Advanced Digestive Cancer. Journal of Translational Medicine, 13, Article No. 277.
https://doi.org/10.1186/s12967-015-0632-8
|
[37]
|
Luevano, M., Daryouzeh, M., Alnabhan, R., Querol, S., Khakoo, S., Madrigal, A. and Saudemont, A. (2012) The Unique Profile of Cord Blood Natural Killer Cells Balances Incomplete Maturation and Effective Killing Function upon Activation. Human Immunology, 73, 248-257. https://doi.org/10.1016/j.humimm.2011.12.015
|
[38]
|
Cavazzana-Calvo, M., Hacein-Bey, S., de Saint Basile, G., De Coene, C., Selz, F., Le Deist, F. and Fischer, A. (1996) Role of Interleukin-2 (IL-2), IL-7, and IL-15 in Natural Killer Cell Differentiation from Cord Blood Hematopoietic Progenitor Cells and from γ c Transduced Severe Combined Immu-nodeficiency X1 Bone Marrow Cells. Blood, 88, 3901-3909. https://doi.org/10.1182/blood.V88.10.3901.bloodjournal88103901
|
[39]
|
Mehta, R.S., Shpall, E.J. and Rezvani, K. (2015) Cord Blood as a Source of Natural Killer Cells. Frontiers in Medicine, 2, Article 93. https://doi.org/10.3389/fmed.2015.00093
|
[40]
|
Knorr, D.A., Ni, Z., Hermanson, D., Hexum, M.K., Bendzick, L., Cooper, L.J., Lee, D.A. and Kaufman, D.S. (2013) Clinical-Scale Derivation of Natural Killer Cells from Human Plu-ripotent Stem Cells for Cancer Therapy. Stem Cells Translational Medicine, 2, 274-283. https://doi.org/10.5966/sctm.2012-0084
|
[41]
|
Dezell, S.A., Ahn, Y.O., Spanholtz, J., Wang, H., Weeres, M., Jack-son, S., Cooley, S., Dolstra, H., Miller, J.S. and Verneris, M.R. (2012) Natural Killer Cell Differentiation from Hemato-poietic Stem Cells: A Comparative Analysis of Heparin- and Stromal Cell-Supported Methods. Transplantation and Cellular Therapy, 18, 536-545.
https://doi.org/10.1016/j.bbmt.2011.11.023
|
[42]
|
Woll, P.S., Grzywacz, B., Tian, X., Marcus, R.K., Knorr, D.A., Verneris, M.R. and Kaufman, D.S. (2009) Human Embryonic Stem Cells Differentiate into a Homogeneous Population of Natural Killer Cells with Potent in Vivo Antitumor Activity. Blood, 113, 6094-6101. https://doi.org/10.1182/blood-2008-06-165225
|
[43]
|
Knorr, D.A. and Kaufman, D.S. (2010) Pluripotent Stem Cell-Derived Natural Killer Cells for Cancer Therapy. Translational Research, 156, 147-154. https://doi.org/10.1016/j.trsl.2010.07.008
|